Research & Projects

Research foci

We have two major interests that fall within our overarching research mission. First, we aim to establish pharmacogenetic predictors of statin efficacy and safety. Second, we aim to advance pharmacogenomic discovery and validation in historically-excluded populations.

Research projects

Pharmacogenomic predictors of statin efficacy and safety

We identified a polygenic risk score that predicts the magnitude of benefit from statin therapy (PMID: 35862449)

Pharmacogenomic discovery and validation in historically excluded populations

A potential clinical consequence when pharmacogenetic dose adjustments from a traditional Eurocentric test panel are used in members of understudied groups. Examples like these have been reported in real life clinical care. (PMID: 36924260)